Conditions: Plaque Psoriasis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 151
Healthy volunteers: no

Brief summary:
The objectives of this study are to evaluate the therapeutic efficacy and safety of DSXS and a Placebo in patients with moderate to severe scalp psoriasis.

Detailed description:
This randomized, double-blind, vehicle-controlled, dose-ranging, parallel-group multi-site study is designed to evaluate the therapeutic efficacy and safety of the investigational product, DSXS, for the treatment of moderate to severe scalp psoriasis at different application times up to 30 minutes.

Arms:
arm 1: DSXS applied once a day for a total of 28 days. arm 2: Placebo (vehicle) applied once a day for a total of 28 days.

Interventions: intervention 1: DSXS1411 intervention 2: Placebo
Intervention descriptions: intervention 1: DSXS (Taro Pharmaceuticals Inc.) intervention 2: Placebo (vehicle) (Taro Pharmaceuticals Inc.)

Protocol document: